Pharmaceutical Filtration Market Research Report by Type, Technique, Forecast - 2023-2027

Pharmaceutical Filtration Market Forecast 2023-2027

The pharmaceutical filtration market size is estimated to grow by USD 10.21 billion at a CAGR of 10.47% between 2022 and 2027. The increasing demand for R&D, supported by government healthcare expenditure, drives innovation and the development of new drugs. The rising number of drug launches reflects the industry's response to the growing prevalence of chronic diseases, which require continuous advancements in medicine. These factors collectively contribute to the expansion and evolution of the market. Additionally, the market's growth is bolstered by the increasing adoption of personalized or customized medical devices, which cater to individual patient needs more effectively. This trend is driven by advancements in technology and a greater understanding of patient-specific requirements, leading to improved treatment outcomes and patient satisfaction. It also includes an in-depth analysis of drivers, trends, and challenges. 

Research and development (R&D) accounts for 15% to 20% of a company's revenue on average. Many companies are making significant investments in this area. For instance, in 2020, Biogen, one of the global manufacturers, expended between 18% and 20% of its revenue on research and development. Similarly, in 2020, F. Hoffmann-La Roche expended approximately 20% of its revenue on R&D. Pharmaceutical manufacturers are expected to spend more money on research and development, which will make more pharmaceutical products available on the market and increase demand for pharmaceutical filtration. Thus, the above factors will increase the market growth during the forecast period.

What will be the size of the Market During the Forecast Period?

To learn more about this report, Request Free Sample

Market Segmentation

This report provides a detailed analysis of the market segmentation by Type (Sterile and Non-sterile ), Technique (Microfiltration, Ultrafiltration, Nanofiltration, and Others ), and Geography (North America, Europe, Asia, and the Rest of the World (ROW)).

By Type

The market share growth by the sterile segment will be significant during the forecast period. Sterilization is a critical procedure in industry that eliminates microorganisms and particles from liquids and gases to guarantee the purity and sterility of products. It is widely utilized in the production of injectable medications, ophthalmic solutions, and various other sterile preparations. The primary objective of sterile filtration is to safeguard patients from potential microbial contamination during the administration of drugs. As the most crucial filtration process in the field, the demand for sterile filtration is expected to increase in the coming years. This growth will contribute significantly to the overall expansion of the targeted market during the forecast period.

Get a glance at the market contribution of various segments View a PDF Sample

The sterile segment was valued at  USD 6.21 billion in 2017. It is commonly employed to produce injectable drugs, ophthalmic solutions, and other sterile pharmaceutical preparations. The main purpose of sterile filtrations is to protect the patients from potential microbial contamination during drug administration. Since this is the most important filtration process, sterile filtration is expected to grow during the forecast period. Hence contributing to the growth of the market in focus during the forecast period.

By Region

For more insights about the market share of various regions View PDF Sample now!

North America is estimated to contribute 42% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. In North America, the market is being driven by various factors such as the growing value of exports in the US, increased healthcare spending, a rising aging population, the demand for advanced filter products in the industry, improvements in healthcare, and increased research and development activities in the US and Canada. For example, healthcare spending in the US saw a significant increase in 2021, reaching USD 4.3 trillion or USD 12,914 per capita, demonstrating strong growth in this sector. These factors contribute to the expansion of the market.

Buy Now Full Report and Discover More

Key Pharmaceutical Filtration Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

Amazon Filters Ltd: The company offers pharmaceutical filtration solutions such as Ophthalmic solutions for lens care solutions, and for more difficult products that contain viscosity enhancers.

• Danaher Corp.
• Donaldson Co. Inc.
• Eaton Corp. Plc
• ErtelAlsop
• Freudenberg Filtration Technologies GmbH and Co. KG
• General Electric Co.
• Graver Technologies LLC
• KASAG Swiss AG
• MANN HUMMEL International GmbH and Co. KG
• Meissner Filtration Products Inc.
• Merck KGaA
• MMS AG
• Parker Hannifin Corp.
• Porvair Plc
• Repligen Corp.
• Samsung Electronics Co. Ltd.
• Sartorius AG
• Tetra Laval SA
• Thermo Fisher Scientific Inc.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as domination, leading, strong, tentative, and weak.

Market Dynamics and Customer Landscape

The market faces challenges such as membrane fouling and requires significant capital investment in production facilities. Despite these challenges, the market offers attractive opportunities driven by the expansion of the industry, particularly in emerging economies with strong economic growth. However, the market is highly consolidated, posing barriers to entry for new entrants. The market benefits from the ease of installation of membrane filters with various polymers, pore sizes, and diameters for site-specific applications. Advances in nanofiber technology are enhancing filtration efficiency, leading to increased adoption of both single-use filtration systems and reusable filtration systems.  Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. 

Key Market Drivers

Increasing demand for (R&D) due to government healthcare expenditure is driving the market. Achieving a concentrated and pure population of small molecules, cells, proteins, nucleic acids, or clean solutions is crucial across various applications, ranging from laboratory studies to large-scale production. Filter systems come in different sizes, shapes, and materials to cater to diverse needs and comply with government regulations, ensuring product purity and consistency. These companies are making significant investments in research and development (R&D), with an average expenditure of 15%-20% of revenue by companies. This trend is driven by attractive opportunities in emerging economies, economic strength, and advances in nanofiber technology. However, the market faces restraints such as rising R&D spending and the presence of highly consolidated markets, which may pose challenges for new entrants despite the ease of installation of these systems.

For instance, in 2020, Biogen allocated approximately 18%-20% of its revenue to R&D, while F. Hoffmann-La Roche spent around 20% on R&D during the same period. Increased R&D spending by manufacturers is expected to lead to the introduction of more products in the market, driving the demand for pharmaceutical filtration. By outsourcing filtration services, pharmaceutical manufacturers can focus on their core business activities. The growing R&D investments by pharmaceutical manufacturers are anticipated to fuel the demand for comprehensive filtration, enabling product differentiation in the market.

Significant Market Trends

The increasing number of US FDA-approved manufacturing facilities is the trend in the market growth. Achieving a concentrated and pure population of small molecules, cells, proteins, nucleic acids, or clean solutions is crucial across various applications, ranging from laboratory studies to large-scale pharmaceutical production. Filter systems come in different sizes, shapes, and materials to cater to diverse needs and comply with government regulations, ensuring product purity and consistency. These companies are making significant investments in research and development (R&D), with an average expenditure of 15%-20% of revenue by pharmaceutical companies. For instance, in 2020, Biogen allocated approximately 18%-20% of its revenue to R&D, while F. Hoffmann-La Roche spent around 20% on R&D during the same period. Increased R&D spending by pharmaceutical manufacturers is expected to lead to the introduction of more pharmaceutical products in the market, driving the demand for pharmaceutical filtration.

Moreover, outsourcing filtration operations to third-party players allows pharmaceutical manufacturers to reduce capital expenditure and operating costs associated with acquiring filtration machinery, dedicated space, and labor. By outsourcing filtration services, pharmaceutical manufacturers can focus on their core business activities. The growing R&D investments by pharmaceutical manufacturers are anticipated to fuel the demand for comprehensive pharmaceutical filtration, enabling product differentiation in the market.

Major Market Challenges

Risks of counterfeiting in pharmaceutical filtration are challenging the market growth. The pharmaceutical industry faces a significant risk of counterfeit products within its supply chain, posing dangers to consumers' lives and financial implications for companies. Furthermore, the negative consequences of counterfeit drugs can severely damage a brand's reputation. The global pharmaceutical supply chain, characterized by numerous intermediaries, increases the likelihood of theft or substitution of genuine products with counterfeit ones. Such incidents can occur at various stages, from the beginning to the end of the supply chain, before reaching the end customer.

To mitigate the risk of counterfeiting in the pharmaceutical industry, the US federal government implemented the Drug Quality and Security Act in 2013. This act aims to establish complete traceability of pharmaceutical products by 2023. Through the implementation of serialization across the supply chain, the traceability system enhances efficiency and enables pharmaceutical manufacturers, hospitals, and pharmacies to track prescription drugs throughout their journey. Recent years have witnessed instances where counterfeit or fake products have infiltrated the supply chain during reverse logistics operations, potentially impacting the growth of the targeted market during the forecast period.

Buy Now Full Report and Discover More

Key Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Market Customer Landscape

Segment Overview

The market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027. 

• Type Outlook 
  • Sterile
  • Non-sterile

• Technique Outlook 
  • Microfiltration
  • Ultrafiltration
  • Nanofiltration
  • Others

• Region Outlook 
  • North America
    • The U.S.
    • Canada
  • Europe
    • The U.K.
    • Germany
    • France
    • Rest of Europe
  • Asia
    • China
    • India
  • ROW
    • Argentina
    • Australia
    • Brazil

Market Analyst Overview

The market is influenced by various factors, including worldwide pharmaceutical R&D spending and the requirement of high capital investments for manufacturing filtration systems or equipment. Assumptions about technical know-how and the availability of skilled personnel impact the overall manufacturing costs, particularly for large tangential flow filtration (TFF) systems. Despite the capital intensive nature of the market, smaller players have an opportunity due to the low manufacturing cost advantage.

Moreover, the market is driven by the expansion of the pharmaceutical industry and the adoption of GMP manufacturing practices. Depth filters and other filters play a crucial role in ensuring the purity of pharmaceutical drugs by minimizing the risk of membrane fouling and cross-contamination. With an increasing focus on biopharmaceutical manufacturing facilities, the demand for filtration assemblies and high throughput filtration technologies is growing. Despite being a highly consolidated market, there is still room for innovation, especially in the development of innovative biologics. The market is also influenced by factors such as the R&D budget and the intellectual property system governing pharmaceuticals.

Market Scope
Report Coverage	Details
Page number	154
Base year	2022
Historic period	2017-2021
Forecast period	2023-2027
Growth momentum & CAGR	Accelerate at a CAGR of 10.47%
Market growth 2023-2027	USD 10.21 billion
Market structure	Fragmented
YoY growth 2022-2023(%)	8.64
Regional analysis	North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution	North America at 42%
Key countries	US, Canada, Germany, China, and Japan
Competitive landscape	Leading companies, Market Positioning of companies, Competitive Strategies, and Industry Risks
Key companies profiled	Amazon Filters Ltd., Danaher Corp., Donaldson Co. Inc., Eaton Corp. Plc, ErtelAlsop, Freudenberg Filtration Technologies GmbH and Co. KG, General Electric Co., Graver Technologies LLC, KASAG Swiss AG, MANN HUMMEL International GmbH and Co. KG, Meissner Filtration Products Inc., Merck KGaA, MMS AG, Parker Hannifin Corp., Porvair Plc, Repligen Corp., Samsung Electronics Co. Ltd., Sartorius AG, Tetra Laval SA, and Thermo Fisher Scientific Inc.
Market dynamics	Parent market analysis, Market Forecasting, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

View Sample PDF at your Fingertips

What are the Key Data Covered in this Market Research Report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the market growth and forecasting of the market between 2023 and 2027
• Precise estimation of the market size and its contribution to the parent market
• Accurate predictions about upcoming market trends and analysis and changes in consumer behavior
• Growth of the market across Europe, North America, APAC, South America, and Middle East and Africa
• Thorough market growth analysis of the market’s competitive landscape and detailed information about companies
• Comprehensive market analysis and report on the factors that will challenge the market research and growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch